Effect of Modulen <i>vs</i> budesonide on clinical response and mucosal healing in Crohn’s patients
Both interventions have a role in CD treatment. Yet, their effects differ and may complement each other: Modulen yields clinical and mucosal improvements, while budesonide primarily leads mainly to laboratory improvements.
Authors
- O. Gal (ORCID: https://orcid.org/0000-0003-3570-4545)
- Eva Niv
- Yael Kopelman (ORCID: https://orcid.org/0000-0002-7622-1593)
- Sara Stern Katie
- Elisabeth Mahajna
- Baruch Ovadia
Institutions
- Technion – Israel Institute of Technology (IL)
- Hillel Yaffe Medical Center (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.3748/wjg.v31.i5.100238
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.10